Hos patienter med patente nasolacrimale kanaler formodes topikal okulær administration af OPATANOL at reducere nasale tegn og symptomer, som hyppigt ledsager sæsonbetinget allergisk conjunctivitis.
In patients with patent nasolacrimal ducts, topical ocular administration of OPATANOL was suggested to reduce the nasal signs and symptoms that frequently accompany seasonal allergic conjunctivitis.